KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword.
Franciele Cabral PinheiroFernanda Sperb-LudwigIda Vanessa Doederlein SchwartzPublished in: Cellular and molecular life sciences : CMLS (2020)
Keyphrases